# Generative AI Drug Discovery System
![image](https://github.com/user-attachments/assets/e1425660-42c1-4db1-9123-f2a252660f57)

## Overview
This project is a **Generative AI Drug Discovery System** using **Next.js** for the frontend and **FastAPI** for the backend. The system integrates various biomedical data sources, AI models, and cloud services to enable drug discovery and monetization.

## System Architecture
The system consists of the following components:

### 1. Frontend (Next.js)
- Dashboard for monitoring system activity
- Data source management for biomedical databases
- Molecule generation interface using AI models
- Drug-target interaction prediction tools
- Advanced 3D molecule visualization with WebGL
- Real-time collaborative drug design tools
![image](https://github.com/user-attachments/assets/d372c2b6-df74-4043-8d99-c8280726bd9d)

### 2. Backend (FastAPI)
- Data collection and processing from biomedical databases
- Molecule generation using AI models
- Drug-target interaction prediction
- Authentication and user management
- AI-powered property prediction and analysis

### 3. AI Models Integration
- Transformer-based models (**MolBART, ChemBERTa**) for molecule generation
- **AlphaFold** and **AutoDock Vina** for drug-target interaction prediction
- Integration with AI SDK for model management
- Real-time AI-powered scientific assistant

### 4. Data Processing
- **RDKit** for molecular data processing and property calculation
- **DeepChem** for advanced molecular modeling and prediction
- AI-based chemical property estimation

### 5. Cloud Deployment
- Containerization with **Docker**
- Orchestration with **Kubernetes**
- Scalable infrastructure on **AWS/GCP/Azure**
- Serverless AI model hosting with AWS SageMaker, Vertex AI, or Azure ML
![image](https://github.com/user-attachments/assets/5e4992b0-6136-4ff2-b959-c8fee7979386)

## Implementation Details

### Data Collection
The system connects to multiple biomedical databases:
- **ChEMBL** for bioactivity data
- **DrugBank** for comprehensive drug information
- **PubChem** for chemical substance data
- **PDBbind** for protein-ligand binding data

### Molecule Generation
- AI models to generate novel drug candidates
- Property prediction to evaluate drug-likeness
- Visualization tools to inspect molecular structures

### Drug-Target Interaction Prediction
- Uses **AlphaFold** for protein structure prediction
- Implements molecular docking with **AutoDock Vina**
- Provides detailed interaction analysis

### Advanced 3D Molecular Visualization
- Realistic bond visualization using WebGL (Three.js + Mol Viewer)
- Precise atomic bond angles and electrostatic surface mapping
- Interactive zoom/pan/rotate features
- Multiple display modes (ball-and-stick, space-filling, wireframe)

### AI-Powered Molecule Property Prediction
- Comprehensive property prediction using AI models
- Detailed analysis of physicochemical properties
- Drug-likeness assessment based on Lipinski's Rule of Five
- Bioactivity predictions for common drug targets
- Toxicity alerts and risk assessment

### Real-Time Collaborative Drug Design
- Interactive AI-powered scientific assistant for researchers
- Natural language drug generation and property analysis
- Attachment of molecular structures and research papers
- Contextual suggestions based on research topics

### Security and Authentication
- **JWT-based authentication**
- **Role-based access control**
- Secure API key storage using environment variables
- Federated learning for privacy-preserving collaboration

## Monetization Strategy
- **SaaS Subscriptions**: Tiered access for biotech firms
- **Model Licensing**: Enterprise licensing for pharmaceutical companies
- **Research Partnerships**: Collaboration with research hospitals
- **API Access Marketplace**: Allow monetization via API access

## Deployment Instructions

### 1. Set up environment variables:
```plaintext
# API Keys
OPENAI_API_KEY=your_openai_api_key
CHEMBL_API_KEY=your_chembl_api_key
DRUGBANK_API_KEY=your_drugbank_api_key
PUBCHEM_API_KEY=your_pubchem_api_key

# Database Configuration
DATABASE_URL=your_database_connection_string

# Authentication
NEXTAUTH_SECRET=your_nextauth_secret
NEXTAUTH_URL=http://localhost:3000

# Cloud Services
AWS_ACCESS_KEY_ID=your_aws_access_key
AWS_SECRET_ACCESS_KEY=your_aws_secret_key
```

### 2. Build and deploy the Docker containers:
```sh
# Build the frontend and backend containers
docker build -t drug-discovery-frontend ./frontend
docker build -t drug-discovery-backend ./backend

# Push to container registry
docker push your-registry/drug-discovery-frontend
docker push your-registry/drug-discovery-backend
```

### 3. Deploy to Kubernetes:
```sh
kubectl apply -f kubernetes/deployment.yaml
kubectl apply -f kubernetes/service.yaml
kubectl apply -f kubernetes/ingress.yaml
```

### 4. Set up monitoring and scaling:
```sh
kubectl apply -f kubernetes/monitoring.yaml
kubectl apply -f kubernetes/autoscaling.yaml
```

## Technical Implementation

### AI Model Integration
```typescript
import { generateText, generateObject } from 'ai';
import { openai } from '@ai-sdk/openai';

// Generate molecule using AI
const { text: smiles } = await generateText({
  model: openai('gpt-4o'),
  prompt: `Generate a SMILES notation for a drug molecule with properties: ${properties}`,
});

// Predict properties using structured output
const { object: prediction } = await generateObject({
  model: openai('gpt-4o'),
  schema: predictionSchema,
  prompt: `Predict properties for molecule: ${smiles}`,
});
```

### Advanced 3D Molecular Visualization
```typescript
import { MolViewer } from '@/components/MolViewer';

// Render high-fidelity 3D molecular structure
<MolViewer 
  moleculeData={smiles} 
  displayOptions={{ 
    bondingMode: 'covalent', 
    chargeMapping: true, 
    rotation: true 
  }} 
/>
```

### Molecular Processing
```typescript
// RDKit for molecular property calculation
import { calculateProperties, validateSmiles } from '@/lib/rdkit-utils';

const properties = calculateProperties(smiles);
const isValid = validateSmiles(smiles);

// DeepChem for advanced predictions
import { predictBindingAffinity } from '@/lib/deepchem-utils';

const prediction = await predictBindingAffinity(molecule, target);
```

### AI-Powered Property Prediction Backend
```python
from rdkit import Chem
from rdkit.Chem import rdMolTransforms
from deepchem.feat import RDKitDescriptors
from deepchem.models import GraphConvModel

# Generate 3D conformer
def generate_3d_molecule(smiles):
    mol = Chem.MolFromSmiles(smiles)
    mol = Chem.AddHs(mol)
    return Chem.AllChem.EmbedMolecule(mol)

# Optimize bond angles
def optimize_bond_angles(mol):
    Chem.rdMolTransforms.CanonicalizeConformer(mol.GetConformer())
    return mol

# Feature Extraction
def extract_features(smiles):
    featurizer = RDKitDescriptors()
    features = featurizer.featurize([smiles])
    return features

# AI Prediction
def predict_properties(features):
    model = GraphConvModel(1)
    prediction = model.predict(features)
    return prediction
```

### API Enhancements for Data Integration
```python
import requests

def fetch_chembl_data(molecule_id):
    url = f"https://chembl.com/api/v1/molecule/{molecule_id}"
    response = requests.get(url)
    return response.json()
```

### Data Pipeline
1. Data collection from biomedical databases
2. Data preprocessing and normalization
3. Feature extraction for machine learning
4. Model training and validation
5. Inference and prediction

## Scaling and Future Enhancements
- **Horizontal Scaling**: Add more compute nodes for parallel processing
- **Model Optimization**: Fine-tune models for specific therapeutic areas
- **API Expansion**: Develop additional endpoints for specialized tasks
- **Collaboration Features**: Add tools for team collaboration
- **Federated Learning**: Implement privacy-preserving machine learning
- **Quantum AI Models**: Use for deeper molecular interactions
- **Blockchain Security**: Store research data with tamper-proof security
- **Synthetic Route Prediction**: AI-powered synthesis planning
- **Laboratory Automation Integration**: Connect with robotic systems

## Conclusion
This **Generative AI Drug Discovery System** provides a comprehensive platform for biotech and pharmaceutical companies to accelerate their drug discovery process. By leveraging AI models, molecular modeling tools, and cloud infrastructure, the system enables researchers to generate novel drug candidates, predict their properties, and evaluate their potential efficacy.

The modular architecture allows for easy extension and customization, while the **SaaS model** provides a sustainable business approach. With proper deployment and scaling, this system can significantly reduce the time and cost associated with traditional drug discovery methods.

By combining high-fidelity visualization, AI-powered analysis, collaborative tools, and secure infrastructure, the system accelerates the drug discovery process and enables researchers to develop novel therapeutics more efficiently.
